诚达药业
(301201)
| 流通市值：38.38亿 | | | 总市值：54.71亿 |
| 流通股本：1.09亿 | | | 总股本：1.55亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 229,824,922.47 | 431,099,526.55 | 725,803,345.74 | 805,743,567.74 |
| 交易性金融资产 | 755,576,366.2 | 533,038,526.41 | 270,080,232.11 | 177,159,784.4 |
| 应收票据及应收账款 | 118,311,578.88 | 141,780,681.02 | 107,738,757.14 | 105,354,563.27 |
| 其中：应收票据 | 649,000 | 9,005,466.48 | 10,000 | 46,917.01 |
| 应收账款 | 117,662,578.88 | 132,775,214.54 | 107,728,757.14 | 105,307,646.26 |
| 应收款项融资 | 2,354,983.06 | - | 3,586,503.13 | 3,728,925 |
| 预付款项 | 13,207,977.37 | 9,460,761.19 | 2,444,467.46 | 10,875,270.41 |
| 其他应收款合计 | 405,672.92 | 518,017.82 | 419,485.52 | 881,992.92 |
| 存货 | 165,925,066.28 | 146,847,221.38 | 148,433,639.03 | 154,088,837.95 |
| 合同资产 | - | - | - | 1,009,275.25 |
| 其他流动资产 | 34,518,902.23 | 38,270,796.83 | 45,795,035.83 | 36,738,944.29 |
| 流动资产合计 | 1,320,125,469.41 | 1,301,015,531.2 | 1,304,301,465.96 | 1,295,581,161.23 |
| 非流动资产: | | | | |
| 长期股权投资 | 64,042,244.68 | 66,711,257.5 | 68,479,878.55 | - |
| 其他权益工具投资 | - | - | - | 77,410,000 |
| 投资性房地产 | 35,705,449.01 | 35,991,142.58 | 36,276,836.15 | 45,683,997.78 |
| 固定资产 | 753,832,560.07 | 719,792,553.57 | 730,810,834.38 | 730,604,348.61 |
| 在建工程 | 55,551,998.77 | 101,358,391.54 | 108,191,051.88 | 115,601,483.43 |
| 无形资产 | 36,876,885.32 | 37,374,240.29 | 37,163,630.66 | 35,490,589.91 |
| 长期待摊费用 | 42,366,351.59 | 44,317,584.11 | 48,924,150.21 | 41,278,413.14 |
| 递延所得税资产 | 14,548,002.33 | 13,984,244.93 | 13,335,251.93 | 8,735,916.73 |
| 其他非流动资产 | 27,613,013.21 | 11,654,093.8 | 2,400,000 | 18,188,759.81 |
| 非流动资产合计 | 1,030,536,504.98 | 1,031,183,508.32 | 1,045,581,633.76 | 1,072,993,509.41 |
| 资产总计 | 2,350,661,974.39 | 2,332,199,039.52 | 2,349,883,099.72 | 2,368,574,670.64 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 173,755,968.29 | 142,466,270.75 | 164,631,696.13 | 157,810,190.81 |
| 其中：应付票据 | 4,419,802.91 | 11,321,120.73 | 20,957,520.4 | 20,388,571.26 |
| 应付账款 | 169,336,165.38 | 131,145,150.02 | 143,674,175.73 | 137,421,619.55 |
| 预收款项 | 215,886.75 | 79,851.37 | 260,164.1 | 84,255.03 |
| 合同负债 | 2,303,542.18 | 4,887,410.87 | 3,352,899.3 | 2,931,081.25 |
| 应付职工薪酬 | 5,236,143.04 | 5,431,330.16 | 7,168,352.18 | 4,275,382.29 |
| 应交税费 | 2,523,595.45 | 488,256.56 | 8,514,785.96 | 5,201,575.45 |
| 其他应付款合计 | 3,403,972.52 | 3,607,035.12 | 4,217,263.18 | 5,142,236.35 |
| 一年内到期的非流动负债 | 14,802,424.74 | 14,811,838.6 | 14,812,063.47 | 40,738.38 |
| 其他流动负债 | 0 | - | 10,000 | - |
| 流动负债合计 | 202,241,532.97 | 171,771,993.43 | 202,967,224.32 | 175,485,459.56 |
| 非流动负债: | | | | |
| 长期借款 | 36,918,840.83 | 44,302,609.05 | 44,302,609.05 | 58,197,679.9 |
| 递延收益 | 10,639,902.58 | 10,838,445.76 | 4,716,988.94 | 1,915,532.12 |
| 递延所得税负债 | 1,518,230 | 1,213,348.76 | 845,419.68 | 783,187.91 |
| 非流动负债合计 | 49,076,973.41 | 56,354,403.57 | 49,865,017.67 | 60,896,399.93 |
| 负债合计 | 251,318,506.38 | 228,126,397 | 252,832,241.99 | 236,381,859.49 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 154,713,824 | 154,713,824 | 154,713,824 | 154,713,824 |
| 资本公积 | 1,693,847,004.52 | 1,693,847,004.52 | 1,693,847,004.52 | 1,693,936,183.68 |
| 减:库存股 | 57,073,347.67 | 57,073,347.67 | 57,073,347.67 | 57,073,347.67 |
| 其他综合收益 | -25,500,000 | -25,500,000 | -25,500,000 | -19,201,500 |
| 盈余公积 | 58,795,538.86 | 58,795,538.86 | 58,795,538.86 | 58,491,579.28 |
| 未分配利润 | 271,960,292.53 | 276,662,539.06 | 269,660,585.71 | 298,663,667.51 |
| 归属于母公司股东权益合计 | 2,096,743,312.24 | 2,101,445,558.77 | 2,094,443,605.42 | 2,129,530,406.8 |
| 少数股东权益 | 2,600,155.77 | 2,627,083.75 | 2,607,252.31 | 2,662,404.35 |
| 股东权益合计 | 2,099,343,468.01 | 2,104,072,642.52 | 2,097,050,857.73 | 2,132,192,811.15 |
| 负债和股东权益合计 | 2,350,661,974.39 | 2,332,199,039.52 | 2,349,883,099.72 | 2,368,574,670.64 |
| 公告日期 | 2026-08-26 | 2026-04-28 | 2026-04-28 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |